Related references
Note: Only part of the references are listed.Association between gene expression profile of the primary tumor and chemotherapy response of metastatic breast cancer
Cemile Dilara Savci-Heijink et al.
BMC CANCER (2017)
A novel gene expression signature for bone metastasis in breast carcinomas
C. Dilara Savci-Heijink et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Retrospective analysis of metastatic behaviour of breast cancer subtypes
C. Dilara Savci-Heijink et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
Xin Ye et al.
NATURE (2015)
Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines
Jacky M. Tiang et al.
CANCER MEDICINE (2015)
Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer
Yumi Endo et al.
BMC CANCER (2014)
Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
Tuan Zea Tan et al.
EMBO MOLECULAR MEDICINE (2014)
Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis
Steven M. Frisch et al.
JOURNAL OF CELL SCIENCE (2013)
The epigenetics of epithelial-mesenchymal plasticity in cancer
Wai Leong Tam et al.
NATURE MEDICINE (2013)
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
M. Angela Nieto
SCIENCE (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
R. Y-J Huang et al.
CELL DEATH & DISEASE (2013)
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
J. Chuck Harrell et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State
Wenjun Guo et al.
CELL (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transition
Yanhong Zhang et al.
MODERN PATHOLOGY (2012)
Meta-Analysis of Gene Expression Signatures Defining the Epithelial to Mesenchymal Transition during Cancer Progression
Christian J. Groeger et al.
PLOS ONE (2012)
To differentiate or not - routes towards metastasis
Thomas Brabletz
NATURE REVIEWS CANCER (2012)
Arylamine N-Acetyltransferase 1: A Novel Drug Target in Cancer Development
Neville J. Butcher et al.
PHARMACOLOGICAL REVIEWS (2012)
Twist1-Induced Invadopodia Formation Promotes Tumor Metastasis
Mark A. Eckert et al.
CANCER CELL (2011)
MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem Cells
Amy N. Abell et al.
CELL STEM CELL (2011)
RNAi-Mediated Knock-Down of Arylamine N-acetyltransferase-1 Expression Induces E-cadherin Up-Regulation and Cell-Cell Contact Growth Inhibition
Jacky M. Tiang et al.
PLOS ONE (2011)
Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?
Dejuan Kong et al.
Cancers (2011)
Small molecule inhibition of arylamine N-acetyltransferase Type I inhibits proliferation and invasiveness of MDA-MB-231 breast cancer cells
Jacky M. Tiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Small Molecule Colorimetric Probes for Specific Detection of Human Arylamine N-Acetyltransferase 1, a Potential Breast Cancer Biomarker
Nicola Laurieri et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition
Muh-Hwa Yang et al.
NATURE CELL BIOLOGY (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
Joseph H. Taube et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition
Erica L. McCoy et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Up-regulation of MSX2 enhances the malignant phenotype and is associated with Twist 1 expression in human pancreatic cancer cells
Kennichi Satoh et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Methylation of the TWIST1 Promoter, TWIST1 mRNA Levels, and Immunohistochemical Expression of TWIST1 in Breast Cancer
Eelke H. Gort et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Regulation of cancer cell survival, migration, and invasion by twist: AKT2 comes to interplay
George Z. Cheng et al.
CANCER RESEARCH (2008)
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype
David Sarrió et al.
CANCER RESEARCH (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma
Mikio Terauchi et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer
H-F Yuen et al.
HISTOPATHOLOGY (2007)
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors
Jeffrey B. Wyckoff et al.
CANCER RESEARCH (2007)
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
Jason I. Herschkowitz et al.
GENOME BIOLOGY (2007)
Significance of TWIST expression and its association with E-cadherin in bladder cancer
Zheng Zhang et al.
HUMAN PATHOLOGY (2007)
Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition
Terence K. Lee et al.
CLINICAL CANCER RESEARCH (2006)
Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines
Anthony D. Yang et al.
CLINICAL CANCER RESEARCH (2006)
Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton
A Wicki et al.
CANCER CELL (2006)
The epithelial-mesenchymal transition: new insights in signaling, development, and disease
JM Lee et al.
JOURNAL OF CELL BIOLOGY (2006)
Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis
Jason J. Christiansen et al.
CANCER RESEARCH (2006)
Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer
Y Mironchik et al.
CANCER RESEARCH (2005)
TWIST is expressed in human gliomas and promotes invasion
MC Elias et al.
NEOPLASIA (2005)
The fallacy of epithelial mesenchymal transition in neoplasia
D Tarin
CANCER RESEARCH (2005)
Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer
TA Martin et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-cripto-1 transgenic mice
L Strizzi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung
J Mehrotra et al.
CLINICAL CANCER RESEARCH (2004)
Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice
KS Sugamori et al.
MOLECULAR PHARMACOLOGY (2003)
Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment
T Brabletz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
